These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2889239)

  • 1. The molecular pathology of haemophilia.
    Larner AJ
    Q J Med; 1987 Jun; 63(242):473-91. PubMed ID: 2889239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics and counselling in haemophilia.
    Peake I
    Thromb Haemost; 1995 Jul; 74(1):40-4. PubMed ID: 8578494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier detection and prenatal diagnosis in families with haemophilia.
    Shetty S; Ghosh K; Bhide A; Mohanty D
    Natl Med J India; 2001; 14(2):81-3. PubMed ID: 11396323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of factor IX: defects in haemophilia B.
    McGraw RA; Davis LM; Lundblad RL; Stafford DW; Roberts HR
    Clin Haematol; 1985 Jun; 14(2):359-83. PubMed ID: 3899439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of carriers of haemophilia by polymerase chain reaction.
    Winter PC; Butler EE
    Ulster Med J; 1993 Apr; 62(1):21-8. PubMed ID: 8100097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic engineering and coagulation factors.
    Fass DN; Toole JJ
    Clin Haematol; 1985 Jun; 14(2):547-70. PubMed ID: 3930118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indirect prenatal molecular diagnostic of haemophilia A and B].
    Morales-Machín A; Borjas-Fajardo L; Zabala W; Alvarez F; Fernández E; Zambrano M; Delgado W; Hernández ML; Solis-Añez E; Chacín JA
    Invest Clin; 2008 Sep; 49(3):289-97. PubMed ID: 18846770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic questions of hemophilia].
    Weissbach G; Lenk H
    Z Gesamte Inn Med; 1981 Jun; 36(11):363-70. PubMed ID: 6795839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diagnosis of haemophilia and other inherited bleeding disorders.
    Peyvandi F; Jayandharan G; Chandy M; Srivastava A; Nakaya SM; Johnson MJ; Thompson AR; Goodeve A; Garagiola I; Lavoretano S; Menegatti M; Palla R; Spreafico M; Tagliabue L; Asselta R; Duga S; Mannucci PM
    Haemophilia; 2006 Jul; 12 Suppl 3():82-9. PubMed ID: 16684001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.
    Bi L; Lawler AM; Antonarakis SE; High KA; Gearhart JD; Kazazian HH
    Nat Genet; 1995 May; 10(1):119-21. PubMed ID: 7647782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetics of hemophilia A].
    De Brasi CD; Slavutsky IR; Larripa IB
    Medicina (B Aires); 1996; 56(5 Pt 1):509-17. PubMed ID: 9239887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New high-technology products for the treatment of haemophilia.
    Pipe SW; Saint-Remy JM; Walsh CE
    Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
    Briët E; Mauser-Bunschoten EP
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2566-71. PubMed ID: 9555158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Structure and function of factor VIII and factor IX gene and molecular DNA diagnosis in hemophilia A and B].
    Herrmann FH; Wehnert M; Wulff K
    Z Arztl Fortbild (Jena); 1988; 82(22):1116-22. PubMed ID: 2907834
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor VIII gene mutations and RFLP analysis in hemophilia A.
    Krepelová A; Brdicka R; Vorlová Z
    Stem Cells; 1993 May; 11 Suppl 1():72-6. PubMed ID: 8100465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors impeding efficient expression of factor VIII complementary DNA minigenes.
    Hoeben RC; Fallaux FJ; Schagen FH; van der Eb MM; van Ormondt H; van der Eb A
    Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S15-21. PubMed ID: 9607109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
    Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
    Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.